---
figid: PMC11860879__fimmu-16-1542326-g004
figtitle: Applications of NPs to reverse the non-immune TME in AOC
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11860879
filename: fimmu-16-1542326-g004.jpg
figlink: /pmc/articles/PMC11860879/figure/F4/
number: F4
caption: Applications of NPs to reverse the non-immune TME in AOC. NPs destroy tumors
  by promoting apoptosis, inhibiting proliferation, disrupting HR repair and reversing
  EMT. (A)(a)(a) miR497/TP-HENPs can promote apoptosis by inhibiting PI3K/AKT/mTOR
  signaling pathway. Sal-AgNPs and IDEM-DOXO promote AOC cell apoptosis by activating
  Caspase-3-depended signaling pathways. (b) RGD-CaPO/DOX NPs and R-Se@MEF2D-siRNA
  induce apoptosis directly via increasing ROS preparation, mitochondrial damage and
  ER stress. (B) R-Se@MEF2D-siRNA also inhibits cells proliferation by blocking the
  WNT/β-catenin signaling pathway. (C) MEnZn-CuO NPs decreases the expression of HR
  repairing markers associated with DNA repair mechanisms. (D) GNPs reverse EMT by
  inactivates PI3K/AKT signaling pathway and MAPK signaling pathway
papertitle: 'A new strategy for the treatment of advanced ovarian cancer: utilizing
  nanotechnology to regulate the tumor microenvironment'
reftext: Zixuan Xiong, et al. Front Immunol. 2025;16(NA).
year: '2025'
doi: 10.3389/fimmu.2025.1542326
journal_title: Frontiers in Immunology
journal_nlm_ta: Front Immunol
publisher_name: Frontiers Media SA
keywords: advanced ovarian cancer (AOC) | tumor microenvironment (TME) | chemo-immunotherapy
  | drug resistance | nanotechnology
automl_pathway: 0.8093174
figid_alias: PMC11860879__F4
figtype: Figure
redirect_from: /figures/PMC11860879__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11860879__fimmu-16-1542326-g004.html
  '@type': Dataset
  description: Applications of NPs to reverse the non-immune TME in AOC. NPs destroy
    tumors by promoting apoptosis, inhibiting proliferation, disrupting HR repair
    and reversing EMT. (A)(a)(a) miR497/TP-HENPs can promote apoptosis by inhibiting
    PI3K/AKT/mTOR signaling pathway. Sal-AgNPs and IDEM-DOXO promote AOC cell apoptosis
    by activating Caspase-3-depended signaling pathways. (b) RGD-CaPO/DOX NPs and
    R-Se@MEF2D-siRNA induce apoptosis directly via increasing ROS preparation, mitochondrial
    damage and ER stress. (B) R-Se@MEF2D-siRNA also inhibits cells proliferation by
    blocking the WNT/β-catenin signaling pathway. (C) MEnZn-CuO NPs decreases the
    expression of HR repairing markers associated with DNA repair mechanisms. (D)
    GNPs reverse EMT by inactivates PI3K/AKT signaling pathway and MAPK signaling
    pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MIR497
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - NPS
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - BRCA1
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - LEF1
  - TCF7
  - TCF7L1
  - TCF7L2
  - HNF4A
  - MEF2D
  - TGFB1
  - TGFB2
  - TGFB3
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - AKT1
  - AKT2
  - AKT3
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - ITK
  - SLC22A3
  - Cytochrome C
  - ROS
  - Nucleus
---
